News Johnson & Johnson

Stocks

JNJ

US4781601046

Pharmaceuticals

Market Closed - NYSE Other stock markets 04:00:02 2026-07-13 pm EDT			After hours 05:45:38 pm
257.77 ^USD	+0.31%		257.86	+0.04%

04:47pm	Nasdaq Snaps 3-Day Winning Streak as Oil Jumps Amid US-Iran Tensions	MT
02:22pm	Equities Fall Intraday, Oil Soars as Trump Reinstates Iranian Shipping Blockade in Hormuz	MT

All News

Mentions Relevance

10:53am	TD Cowen Adjusts Price Target on Johnson & Johnson to $300 From $250, Maintains Buy Rating	MT
08:09am	RBC Raises Price Target on Johnson & Johnson to $287 From $265, Keeps Outperform Rating	MT
08:02am	US Equity Futures Drop Pre-Bell as Iran Says Strait of Hormuz Closed Once Again, Oil Prices Jump	MT
Jul. 10	Biopharma Pricing Power Seen as Key Swing Factor for Q2 Earnings, BofA Says	MT
Jul. 10	BofA Securities Adjusts Johnson & Johnson Price Target to $263 From $254	MT
Jul. 09	Goldman Sachs is betting heavily on Johnson & Johnson's Icotyde
Jul. 09	Delhi High Court Grants ₹3.34 Crore Damages To Johnson & Johnson In Counterfeit Medical Devices Case	AQ
Jul. 08	Biopharma Companies' Second-Half Performance to be Largely Driven by Fundamentals, Morgan Stanley Says	MT
Jul. 08	Johnson & Johnson Receives Fda Approval for Dual Energy Thermocool Smarttouch Sf Platform	CI
Jul. 08	Biopharma Sector Seen Shifting to Fundamentals From Macro in H2, Morgan Stanley Says	MT
Jul. 08	Citigroup Adjusts Johnson & Johnson Price Target to $298 From $285	MT
Jul. 08	Johnson & Johnson's Dual Energy Thermocool Smarttouch SF Platform Receives FDA Approval	MT
Jul. 08	Johnson & Johnson Announces FDA Approval for the Dual Energy THERMOCOOL SMARTTOUCH SF Platform	BU
Jul. 08	HEALTH ROUNDS-Newer style hip implant significantly cuts dislocation risk	RE
Jul. 08	Morgan Stanley Adjusts Price Target Johnson & Johnson to $284 From $283, Maintains Overweight Rating	MT
Jul. 06	HSBC Adjusts Price Target on Johnson & Johnson to $290 From $280	MT
Jul. 01	UK Approves J&J's Gemcitabine Delivery System for Bladder Cancer Patients	MT
Jun. 30	Healthcare Stocks Fall as Markets Rotate Back to Tech -- Healthcare Roundup	DJ
Jun. 29	Johnson & Johnson : DePuy Synthes Appoints Christina Zamarro as Chief Financial Officer	PU
Jun. 26	Johnson & Johnson Presents New IMAAVY Data at European Neurology Congress	MT
Jun. 26	Johnson & Johnson Presents New IMAAVY Data at European Academy of Neurology 2026 Congress Reinforcing Sustained Disease Control in Generalized Myasthenia Gravis	CI
Jun. 26	Johnson & Johnson presents new IMAAVY® (nipocalimab-aahu) data at European Academy of Neurology (EAN) 2026 Congress reinforcing sustained disease control in generalized myasthenia gravis	PR
Jun. 26	European Medicines Agency Panel Recommends Label Expansion for Janssen-Cilag's Multiple Myeloma Drug	MT
Jun. 26	EU Regulatory Panel Recommends Expanding Janssen Cilag's Psoriasis Drug Indications	MT
Jun. 26	European Medicines Agency Panel Recommends Change to Marketing Authorization Terms for J&J Unit's HIV-1 Treatment	MT